Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice

Keyphrases

• Aged Mice 100%
• Infant Mice 100%
• Salmonella Enterica Serovar Typhimurium (S. Typhimurium) 100%
• Vaccine Strain 100%
• Vaccine Vector 100%
• Recombinant Attenuated Salmonella 100%
• Attenuation 66%
• Immunogenicity 66%
• Recombinant 33%
• High Dose 33%
• Antigen Expression 33%
• Early childhood 33%
• Host Defense 33%
• Lymphoid Tissue 33%
• Orally Administered 33%
• Disease Symptoms 33%
• Bacterial Vaccines 33%
• Additional mutations 33%
• Salmonella Infection 33%
• Regulated Delayed Attenuation 33%
• Attenuated Salmonella Vaccine 33%

Immunology and Microbiology

• Immunogenicity 100%
• Salmonella Enterica Serovar Typhimurium 100%
• Drug Megadose 50%
• Antigen Expression 50%
• Host Resistance 50%
• Lymphoid Tissue 50%
• Colony-Forming Unit 50%
• Colony Forming Unit S 50%
• Salmonella 50%
• Bacterial Vaccine 50%
• Salmonellosis Vaccine 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Vaccine Strain 100%
• Salmonella Enterica Serovar Typhimurium 100%
• Immunogenicity 66%
• Diseases 66%
• Salmonellosis 33%
• Bacterial Vaccine 33%
• Salmonellosis Vaccine 33%